Healthequity Return on Investment Trend from 2010 to 2022

HQY
 Stock
  

USD 57.67  3.72  6.06%   

Healthequity Return on Investment yearly trend continues to be fairly stable with very little volatility. Return on Investment will likely drop to -0.96 in 2022. During the period from 2010 to 2022, Healthequity Return on Investment regression line of anual values had r-squared of 0.90 and arithmetic mean of  17.21. Healthequity Direct Expenses is fairly stable at the moment as compared to the past year. Healthequity reported Direct Expenses of 332.85 Million in 2021. Cost of Revenue is likely to rise to about 359.1 M in 2022, whereas Consolidated Income is likely to drop (45.5 M) in 2022.
  
Refresh
Check Healthequity financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Healthequity main balance sheet or income statement drivers, such as Direct Expenses of 359.1 M, Cost of Revenue of 359.1 M or Gross Profit of 457.2 M, as well as many exotic indicators such as Interest Coverage of 1.19, Long Term Debt to Equity of 0.71 or PPandE Turnover of 35.09. Healthequity financial statements analysis is a perfect complement when working with Healthequity Valuation or Volatility modules. It can also supplement various Healthequity Technical models. Please check the analysis of Healthequity Correlation against competitors.

Healthequity Return on Investment Breakdown

Showing smoothed Return on Investment of Healthequity with missing and latest data points interpolated. Healthequity's Return on Investment historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Healthequity's overall financial position and show how it may be relating to other accounts over time.
Return on Investment10 Years Trend
Decreasing
Slightly volatile
 Return on Investment 
Share
      Timeline 

Healthequity Return on Investment Regression Statistics

Arithmetic Mean 17.21
Geometric Mean 10.28
Coefficient Of Variation 74.79
Mean Deviation 10.12
Median 17.89
Standard Deviation 12.87
Sample Variance 165.59
Range 33.46
R-Value(0.95)
Mean Square Error 18.40
R-Squared 0.90
Significance 0.00000086
Slope(3.13)
Total Sum of Squares 1,987

Healthequity Return on Investment History

2014 18.95
2015 15.04
2016 17.71
2017 17.89
2018 18.87
2019 5.65
2020 1.47
2021 -0.94
2022 -0.96

About Healthequity Financial Statements

There are typically three primary documents that fall into the category of financial statements. These documents include Healthequity income statement, its balance sheet, and the statement of cash flows. Healthequity investors use historical funamental indicators, such as Healthequity's Return on Investment, to determine how well the company is positioned to perform in the future. Although Healthequity investors may use each financial statement separately, they are all related. The changes in Healthequity's assets and liabilities, for example, are also reflected in the revenues and expenses that we see on Healthequity's income statement, which results in the company's gains or losses. Cash flows can provide more information regarding cash listed on a balance sheet, but not equivalent to net income shown on the income statement. We offer a historical overview of the basic patterns found on Healthequity Financial Statements. Understanding these patterns can help to make the right decision on long term investment in Healthequity. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for 2022
Return on Investment(0.94) (0.96) 
HealthEquity, Inc. provides technology-enabled services platforms to consumers and employers in the United States. The company was incorporated in 2002 and is headquartered in Draper, Utah. Healthequity operates under Health Information Services classification in the United States and is traded on NASDAQ Exchange. It employs 3688 people.

Healthequity Investors Sentiment

The influence of Healthequity's investor sentiment on the probability of its price appreciation or decline could be a good factor in your decision-making process regarding taking a position in Healthequity. The overall investor sentiment generally increases the direction of a stock movement in a one-year investment horizon. However, the impact of investor sentiment on the entire stock markets does not have a solid backing from leading economists and market statisticians.

Healthequity Implied Volatility

    
  37.77  
Healthequity's implied volatility exposes the market's sentiment of Healthequity stock's possible movements over time. However, it does not forecast the overall direction of its price. In a nutshell, if Healthequity's implied volatility is high, the market thinks the stock has potential for high price swings in either direction. On the other hand, the low implied volatility suggests that Healthequity stock will not fluctuate a lot when Healthequity's options are near their expiration.
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Healthequity in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Healthequity's short interest history, or implied volatility extrapolated from Healthequity options trading.

Current Sentiment - HQY

Healthequity Investor Sentiment

Greater number of Macroaxis users are currently bullish on Healthequity. What is your judgment towards investing in Healthequity? Are you bullish or bearish?
Bullish
Bearish
98% Bullish
2% Bearish

Becoming a Better Investor with Macroaxis

Macroaxis puts the power of mathematics on your side. We analyze your portfolios and positions such as Healthequity using complex mathematical models and algorithms, but make them easy to understand. There is no real person involved in your portfolio analysis. We perform a number of calculations to compute absolute and relative portfolio volatility, correlation between your assets, value at risk, expected return as well as over 100 different fundamental and technical indicators.

Build Optimal Portfolios

Align your risk with return expectations

Fix your portfolio
By capturing your risk tolerance and investment horizon Macroaxis technology of instant portfolio optimization will compute exactly how much risk is acceptable for your desired return expectations
Please check the analysis of Healthequity Correlation against competitors. Note that the Healthequity information on this page should be used as a complementary analysis to other Healthequity's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try Idea Breakdown module to analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes.

Complementary Tools for Healthequity Stock analysis

When running Healthequity price analysis, check to measure Healthequity's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Healthequity is operating at the current time. Most of Healthequity's value examination focuses on studying past and present price action to predict the probability of Healthequity's future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move Healthequity's price. Additionally, you may evaluate how the addition of Healthequity to your portfolios can decrease your overall portfolio volatility.
Portfolio Optimization
Compute new portfolio that will generate highest expected return given your specified tolerance for risk
Go
Stock Screener
Find equities using custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook.
Go
Correlation Analysis
Reduce portfolio risk simply by holding instruments which are not perfectly correlated
Go
Portfolio Center
All portfolio management and optimization tools to improve performance of your portfolios
Go
Portfolio Anywhere
Track or share privately all of your investments from the convenience of any device
Go
Is Healthequity's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Healthequity. If investors know Healthequity will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Healthequity listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth YOY
-0.96
Market Capitalization
5.2 B
Quarterly Revenue Growth YOY
0.12
Return On Assets
0.0059
Return On Equity
-0.0299
The market value of Healthequity is measured differently than its book value, which is the value of Healthequity that is recorded on the company's balance sheet. Investors also form their own opinion of Healthequity's value that differs from its market value or its book value, called intrinsic value, which is Healthequity's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Healthequity's market value can be influenced by many factors that don't directly affect Healthequity's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Healthequity's value and its price as these two are different measures arrived at by different means. Investors typically determine Healthequity value by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Healthequity's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.